Get the Stockscreener App
9.94
2.26%
-0.23
After Hours:
9.94
Sensei Biotherapeutics Inc stock is traded at $9.94, with a volume of 51,142.
It is down -2.26% in the last 24 hours and up +10.44% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
See More
Previous Close:
$10.17
Open:
$9.74
24h Volume:
51,142
Relative Volume:
0.78
Market Cap:
$12.54M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-8.3529
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
+3.43%
1M Performance:
+10.44%
6M Performance:
+42.41%
1Y Performance:
+3.52%
1-Day Range:
$9.35
$10.44
1-Week Range:
$9.3201
$11.51
52-Week Range:
$5.00
$18.35
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
9.94 | 12.83M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
Portfolio Recap: Does Sensei Biotherapeutics Inc have pricing powerDay Trade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Valuation Update: Will FG Merger II Corp Equity Right outperform its industry peersNew Guidance & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Treasury Yields: Will Sensei Biotherapeutics Inc benefit from rising consumer demandMarket Volume Summary & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Can Sensei Biotherapeutics Inc. stock rebound after recent weaknessEarnings Miss & Weekly High Potential Stock Alerts - bollywoodhelpline.com
Investor Mood: Whats the MACD signal for Sensei Biotherapeutics Inc2025 Support & Resistance & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Death Cross: What is the Moat Score of Sensei Biotherapeutics IncM&A Rumor & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Retail Surge: Does EQVWS outperform in volatile markets2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
AI Stocks: What is Sensei Biotherapeutics Incs revenue forecastJuly 2025 Retail & Weekly Hot Stock Watchlists - baoquankhu1.vn
Panic Selling: Is Sensei Biotherapeutics Inc in a bullish channelJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Aug Big Picture: Can Sensei Biotherapeutics Inc be the next market leaderJuly 2025 Trends & Free Community Consensus Stock Picks - baoquankhu1.vn
Published on: 2026-01-11 01:29:32 - Улправда
Earnings Update: Will Sensei Biotherapeutics Inc 4070 stock sustain dividend payouts2025 Institutional Moves & Low Risk Entry Point Tips - Bộ Nội Vụ
Why retail investors favor Sensei Biotherapeutics Inc. stockEarnings Trend Report & Accurate Technical Buy Alerts - Улправда
Sensei Biotherapeutics, Inc.Common Stock (NQ: SNSE - FinancialContent
Why Sensei Biotherapeutics Inc. stock is trending among retail tradersPortfolio Return Summary & Weekly Top Stock Performers List - Улправда
Los Angeles Daily NewsSensei Biotherapeutics, Inc.Common Stock (Nasdaq:SNSE) Stock Quote - FinancialContent
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Aug Setups: Why retail investors favor Sensei Biotherapeutics Inc stock2025 Market Outlook & Verified High Yield Trade Plans - moha.gov.vn
What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock - MSN
Will Sensei Biotherapeutics Inc. stock deliver shareholder valueChart Pattern Recognition & Grow Steadily With Our Wealth Roadmap - bollywoodhelpline.com
Sensei Biotherapeutics (NASDAQ:SNSE) Upgraded to “Hold” at Wall Street Zen - Defense World
Sensei Biotherapeutics Updates Executive Retention and Compensation Agreements - TipRanks
Dividend Watch: Will Sensei Biotherapeutics Inc. stock deliver shareholder valueWeekly Gains Summary & Verified Momentum Watchlists - Улправда
How Sensei Biotherapeutics Inc. stock performs in rising dollar environmentEntry Point & Community Verified Swing Trade Signals - Улправда
Sensei Biotherapeutics Earnings Notes - Trefis
What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump? - Sahm
Major Stakeholders Offload Shares in Sensei Biotherapeutics! - TipRanks
Shareholder Peyer Files To Sell 841 Of Sensei Biotherapeutics Inc [SNSE] - TradingView — Track All Markets
Major Stakeholders Offload Sensei Biotherapeutics Shares! - TipRanks
Cambrian Biopharma Sells Shares of Sensei Biotherapeutics - TradingView — Track All Markets
Dir Peyer Sells 21,295 ($232.7K) Of Sensei Biotherapeutics Inc [SNSE] - TradingView — Track All Markets
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Down 8% – What’s Next? - Defense World
Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast - ts2.tech
Sensei Biotherapeutics Inc (SNSE) looking to reclaim success with recent performance - Setenews
How Sensei Biotherapeutics Inc. (4070) stock compares with tech leadersJuly 2025 Outlook & Daily Volume Surge Signals - Newser
Can Sensei Biotherapeutics Inc. (4070) stock deliver double digit returnsWeekly Risk Summary & Capital Efficient Trading Techniques - Newser
How Sensei Biotherapeutics Inc. (4070) stock correlates with oil marketsEarnings Recap Report & Smart Money Movement Tracker - Newser
Can Sensei Biotherapeutics Inc. (4070) stock attract ESG investmentsTrade Exit Report & Low Drawdown Momentum Trade Ideas - Newser
How big funds are accumulating Sensei Biotherapeutics Inc. (4070) stockRecession Risk & Weekly High Potential Alerts - Newser
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Is Sensei Biotherapeutics Inc. stock vulnerable to regulatory risksTreasury Yields & Comprehensive Market Scan Reports - Bộ Nội Vụ
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - MSN
Will Sensei Biotherapeutics Inc. (4070) stock outperform value peersQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
How Sensei Biotherapeutics Inc. (4070) stock reacts to new regulations2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensei Biotherapeutics Inc Stock (SNSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc | 10% Owner |
Dec 09 '25 |
Sale |
8.25 |
6,612 |
54,575 |
155,142 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Option Exercise |
6.40 |
395 |
2,528 |
155,983 |
| Peyer James | 10% Owner |
Dec 09 '25 |
Sale |
7.96 |
3,507 |
27,903 |
155,142 |
| Peyer James | 10% Owner |
Dec 08 '25 |
Sale |
8.59 |
3,105 |
26,672 |
158,254 |
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):